Cyril B. Dousson,David Dukhan,Christophe Claude Parsy,Claire Pierra,Francois-Rene Alexandre,Guillaume Brandt,Daniel Da Costa,Houcine Rahali,Jean-Laurent Paparin,Michel Derock,Thierry Convard,Dominique
申请号:
US13675787
公开号:
US09187496B2
申请日:
2012.11.13
申请国别(地区):
US
年份:
2015
代理人:
摘要:
Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.